止痒润肤凝胶治疗面部皮炎临床地研究

《止痒润肤凝胶治疗面部皮炎临床地研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、ClinicalStudiesofItchGuardandSkinMoistGelinTreatingFacialDermatitisSpecialty：TheSurgeryofTCMAuthor：ZhangYuTutor：Prof.ZhouChun-YingAbstractObjective:Observetheclinicalefficacyofitchguardandskinmoistgelintreatingfacialdermatitis,andexploreitsfunctionmechanism.Met

2、hods:Randomlydividethe90dermatitispatientsintothreegroupswhichisitchguardandskinmoistgeltreatinggroup,compoundcortexphellodendriliquidtreatinggroupandmatrixtreatinggoup.AllpatientsareorallytreatedwithYupingfenggranulesontheconditionthatthecourseoftreatmentis5go

3、netimeand3timeseverydayfor4weeks.Takefacialitchingandflushrange,swellingdegree,papulenumber,xerosiscutisanddesquamationdegreeofskinforobservationindexs.Results:Clinicalobservationafterfourweeksshowsthatthemoreexplicitrateinitchguardandskinmoistgeltreatinggroupi

4、s87.10%,andtheothersare82.76%and23.33%incompoundcortexphellodendriliquidtreatinggroupandmatrixtreatinggoup.Conclusion:Itchguardandskinmoistgelhasmildanddefiniteeffectsontreatingfacialdermatitis.Itsfunctionmechanismisassociatedwithanti-allergicreactionandpromoti

5、ngtherecoveryofbarrierfunctionwithinthedamagedskin.Keywordsgel;facialdermatitis;barrierfunction目录引言...............................................................1止痒润肤凝胶的制备.....................................................21处方组成..............................

6、................................22药品与试剂............................................................23主要实验仪器..........................................................24制备流程..............................................................2止痒润肤凝胶治疗面部皮炎的临床研究..........

7、...........................31研究对象..............................................................31.1一般资料............................................................31.2诊断标准............................................................31.3病例纳入标准....................

8、....................................31.4病例排除标准........................................................41.5病例剔除标准........................................................42研究方